InsiderClue
← All stocks

ADMA BIOLOGICS, INC.

ADMA Balanced
CIK 0001368514 #1977 in the set updated 18 Sep 2026
Bought (120 mo)
$50.14M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$77.56M
$0.00 on a plan · $25.10M straight out of an exercise
Sold at will
$52.46M
28 of 64 sales
Net
−$27.42M
−$2.32M against sales at will

By person

19 insiders · 131 transactions
32.8×

Adam S. Grossman holds 32.8 times base salary in stock. $30.35M of shares against $925.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Adam S. Grossman last reported holding, valued at $7.91, the price Common Stock was last bought or sold at on the open market here, on 27 May 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
PERCEPTIVE ADVISORS LLC entity
10% owner
$33.02M (3)
$4.25M (9)
+$28.78M
28,065,353
12.53%
$222.00M
+25.7%
Biotest Divestiture Trust entity
10% owner
—
$21.80M (2)
−$21.80M
14,405,114
6.43%
$113.94M
−50.0%
Grossman Adam S
President and CEO
$2.28M (16)
$20.91M (31) scheduled
−$18.63M
3,837,160
1.71%
$30.35M
+375.7%
ELMS STEVE
Director
$217.42K (2)
$17.97M (8)
−$17.76M
2,143,750
0.9571%
$16.96M
−40.6%
Biotest AG
10% owner
$12.50M (1)
— (1)
+$12.50M
10,109,534
4.51%
$79.97M
−21.6%
Fong Bryant
Director
—
$5.54M (1)
−$5.54M
83,941
0.0375%
$663.97K
−94.1%
LENZ BRIAN
EVP, CFO
$144.73K (7)
$1.77M (2) scheduled
−$1.62M
703,002
0.3139%
$5.56M
—
Grossman Jerrold B
Director
$1.35M (16)
$2.58M (2) scheduled
−$1.23M
520,459
0.2324%
$4.12M
+3,626%
KWON YOUNG
Director
$197.50K (2)
$1.10M (1)
−$898.10K
263,020
0.1174%
$2.08M
+116.0%
Kestenberg-Messina Kaitlin M.
COO and SVP, Compliance
—
$565.85K (2) scheduled
−$565.85K
443,061
0.1978%
$3.50M
+68.2%
Guiheen Lawrence P.
Director
$265.60K (3)
$768.02K (4)
−$502.42K
136,520
0.0610%
$1.08M
—
Tade Brad L.
CFO and Treasurer
—
$317.25K (1)
−$317.25K
232,940
0.1040%
$1.84M
+64.0%
Mond James
EVP, CSO and CMO
$83.45K (6)
—
+$83.45K
137,535
0.0614%
$1.09M
+3,958%
RICHMAN ERIC I
Director
$78.75K (2)
—
+$78.75K
44,030
0.0197%
$348.28K
+1,158%
DEMSKI MARTHA J
Director
$10.80K (2)
—
+$10.80K
60,801
0.0271%
$480.94K
+1,348%
Kohler Terry
CFO and Treasurer
—
—
—
143,149
0.0639%
$1.13M
+146.7%
FINGER ALISON CECILY
Director
—
—
—
45,619
0.0204%
$360.85K
—
Salas Eduardo Rene
Director
—
—
—
21,579
0.0096%
$170.69K
—
GOLDSTEIN DOV A MD
Director
—
—
—
7,500
0.0033%
$59.33K
—

Individual transactions

36
Insider
Date
Role
Action
Shares
Price
Amount
Grossman Adam S
16 Mar 2026
President and CEO
Sold after exercise
6,000
$15.16
$90.96K
Grossman Adam S
16 Mar 2026
President and CEO
Sold after exercise
15,000
$15.16
$227.40K
Kestenberg-Messina Kaitlin M.
9 Mar 2026
COO and SVP, Compliance
Sold after exercise
10,096
$15.63
$157.80K
Grossman Adam S
17 Feb 2026
President and CEO
Sold after exercise
6,000
$16.08
$96.48K
Grossman Adam S
17 Feb 2026
President and CEO
Sold after exercise
15,000
$16.08
$241.20K
Grossman Adam S
15 Dec 2025
President and CEO
Sold after exercise
6,000
$19.79
$118.74K
Grossman Adam S
15 Dec 2025
President and CEO
Sold after exercise
15,000
$19.79
$296.85K
Grossman Adam S
19 Nov 2025
President and CEO
Sold after exercise
6,000
$16.00
$96.00K
Grossman Adam S
19 Nov 2025
President and CEO
Sold after exercise
15,000
$16.00
$240.00K
Grossman Adam S
24 Oct 2025
President and CEO
Sold after exercise
6,000
$16.00
$96.00K
Grossman Adam S
24 Oct 2025
President and CEO
Sold after exercise
15,000
$16.00
$240.00K
Grossman Adam S
15 Sep 2025
President and CEO
Sold after exercise
6,000
$16.13
$96.78K
Grossman Adam S
15 Sep 2025
President and CEO
Sold after exercise
15,000
$16.13
$241.95K
Grossman Adam S
15 Aug 2025
President and CEO
Sold after exercise
6,000
$16.88
$101.28K
Grossman Adam S
15 Aug 2025
President and CEO
Sold after exercise
15,000
$16.88
$253.20K
Grossman Adam S
15 Jul 2025
President and CEO
Sold after exercise
6,000
$18.66
$111.96K
Grossman Adam S
15 Jul 2025
President and CEO
Sold after exercise
15,000
$18.66
$279.90K
Grossman Adam S
16 Jun 2025
President and CEO
Sold after exercise
6,000
$20.81
$124.86K
Grossman Adam S
16 Jun 2025
President and CEO
Sold after exercise
15,000
$20.81
$312.15K
ELMS STEVE
13 Jun 2025
Director
Sold after exercise
137,931
$20.82
$2.87M
Grossman Jerrold B
9 Jun 2025
Director
Sold after exercise
10,000
$21.31
$213.10K
Guiheen Lawrence P.
22 May 2025
Director
Sold after exercise
1,221
$20.12
$24.57K
Guiheen Lawrence P.
21 May 2025
Director
Sold after exercise
7,779
$20.32
$158.07K
Grossman Adam S
15 May 2025
President and CEO
Sold after exercise
6,000
$19.45
$116.70K
Grossman Adam S
15 May 2025
President and CEO
Sold after exercise
15,000
$19.45
$291.75K
Grossman Adam S
15 Apr 2025
President and CEO
Sold after exercise
6,000
$21.46
$128.76K
Grossman Adam S
15 Apr 2025
President and CEO
Sold after exercise
15,000
$21.46
$321.90K
Grossman Adam S
19 Mar 2025
President and CEO
Sold after exercise
6,000
$18.92
$113.52K
Grossman Adam S
19 Mar 2025
President and CEO
Sold after exercise
15,000
$18.92
$283.80K
Guiheen Lawrence P.
9 Sep 2024
Director
Sold after exercise
9,000
$18.47
$166.19K
Kestenberg-Messina Kaitlin M.
30 Aug 2024
COO and SVP, Compliance
Sold after exercise
24,150
$16.90
$408.05K
Grossman Jerrold B
29 Aug 2024
Director
Sold after exercise
136,861
$17.27
$2.36M
Grossman Adam S
27 Aug 2024
President and CEO
Sold after exercise
389,356
$17.29
$6.73M
Grossman Adam S
26 Aug 2024
President and CEO
Sold after exercise
236,889
$17.69
$4.19M
LENZ BRIAN
15 Aug 2023
EVP, CFO
Sold after exercise
211,578
$4.60
$972.73K
Grossman Adam S
15 Aug 2023
President and CEO
Sold after exercise
510,469
$4.54
$2.32M
Show all 131 transactions →

What was left out

Form 4 filings counted 237
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 9
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 36
Sales at will 28
Transactions with no price 0
Shares from compensation/vesting 15,418,958
Sales filed before the plan box existed 12
History held since 16 Feb 2017